Proactive news headlines including Legacy Minerals, Paradigm Biopharmaceuticals, Antilles Gold and Chimeric Therapeutics – QNT Press Release

[ad_1]

Sydney, April 12, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

  • Legacy Minerals Ltd (ASX:LGM) has received high-grade zinc, lead, gold and silver assay results from drilling at the 100% owned Bauloora Project in New South Wales. Click here
  • Paradigm Biopharmaceuticals Ltd (ASX:PAR)’s lead drug candidate has been fast-tracked by the US Food and Drug Administration (FDA) for a phase three osteoarthritis program. Click here
  • Antilles Gold Ltd ((ASX:AAU, OTCQB:ANTMF) has received further high-grade gold and silver assays from an additional 30 drill holes at the La Demajagua gold/silver deposit in Cuba. Click here
  • Chimeric Therapeutics Ltd (ASX:CHM) has entered into a strategic manufacturing partnership with WuXi Advanced Therapies, a global contract testing and manufacturing organisation, to support its CAR T cell programs. Click here
  • Wiluna Mining Corporation Ltd ((ASX:WMC, OTC:WMXCF) has bolstered its ore reserves for the eponymous Wiluna Mining Centre to 36.8 million tonnes at 1.2 g/t gold for 1.42 million ounces. Click here
  • Aeris Resources Ltd (ASX:AIS) exploration partner Helix Resources Ltd has intersected visible copper sulphide mineralisation from …

Full story available on Benzinga.com

[ad_2]

Source link